Heroin & Other Illicit Drugs
The opioid epidemic is at a critical breaking point that calls for better drug surveillance efforts, but many jurisdictions do not systematically collect, analyze, and apply available data to address our nation’s drug problem. This presentation will highlight valuable resources and tools for public safety and public health officials and demonstrate how their use can improve public health and death investigation efforts and help agencies demonstrate resource and staffing needs to their funding agencies.
The U.S. Drug Enforcement Administration representative will present recent drug trends from the National Forensic Laboratory Information System and summarize the program’s expansion to include medical examiner/coroner offices and public and private toxicology laboratories. The Bureau of Justice Statistics representative will provide an overview of the 2018 Census of Medical Examiner and Coroner Offices and introduce the relevant measures that will provide more intelligence regarding workload, access to investigative resources, and infrastructure-related challenges among the death-investigation community. Representatives of RTI International will show how administrative information from forensic laboratories may be combined with performance metrics to demonstrate to policy- and budget-makers critical resource needs and opioid epidemic opportunity costs, as well as present drug-related calls for service (often 911 calls) data from pilot sites to show how this data — which already are being collected across jurisdictions in the United States — can be used for greater insight into operations and demands on resources.
This session is accredited for the following accreditation types: CME, CNE, CPE, APA, AAFP, AAHCPAD*, NAADAC*, ASWB*
*State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.